ask="17.00"
ask_size="100"
average_daily_volume="164808"
bid="4.15"
bid_size="100"
book_value="0.00"
change="-0.05"
change_from_200_day_moving_average="6.74"
change_from_50_day_moving_average="1.19"
change_from_52_week_high="-3.02"
change_From_52_week_low="4.68"
change_in_percent="-0.46%"
close="10.78"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="0.00"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-1.55"
ex_dividend_date="6/28/2013"
float_shares="N/A"
high="10.90"
high_52_weeks="13.80"
last_trade_date="2/17/2017"
last_trade_price="10.78"
last_trade_size="200"
last_trade_time="4:00pm"
low="10.47"
low_52_weeks="6.10"
market_capitalization="N/A"
moving_average_200_day="4.04"
moving_average_50_day="9.59"
name="Novelion Therapeutics Inc."
notes="N/A"
one_year_target_price="10.00"
open="10.81"
pe_ratio="N/A"
peg_ratio="0.16"
percent_change_from_200_day_moving_average="+167.07%"
percent_change_from_50_day_moving_average="+12.43%"
percent_change_from_52_week_high="-21.88%"
percent_change_from_52_week_low="+76.72%"
previous_close="10.83"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NMS"
symbol="NVLN"
volume="119092"
weeks_range_52="6.10 - 13.80"
